Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers May 26, 2015
Pharmacy Choice - Pharmacy News - May 26, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
5/26/15 - Cancer drugs approved quickly but not to patient's benefit: York University researcher
By a News Reporter-Staff News Editor at Cancer Weekly-- TORONTO, Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. "Drug agencies like the Food and Drug Administration and the European Medicine Agency don't actually look at whether p
5/26/15 - Enrollment Begins in Cellceutix Phase 2 Trial of Brilacidin-OM to Prevent Oral Mucositis in Patients Undergoing Chemoradiation
Cellceutix Corporation, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, and antibiotic applications, is pleased to announce that enrollment has commenced in the Company's Phase 2 clinical trial of Brilacidin-OM for the prevention and treatment of oral mucositis in patients undergoing...
5/26/15 - FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD
--Boehringer Ingelheim today announced that the U.S. Food and Drug Administration approved once-daily STIOLTO� RESPIMAT ® Inhalation Spray. While no treatment slows the rate of decline, maintenance treatment with STIOLTO RESPIMAT initiated at the time of diagnosis will improve lung function, "said Danny McBryan, MD, vice president, Clinical Deve
5/26/15 - InvisionHeart Receives FDA 510(k) Clearance of its InvisionECG Technology
InvisionHeart, a Nashville- based leading developer of a disruptive ECG technology with a secure cloud-based, healthcare IT platform, announced today that the Food and Drug Administration has cleared the InvisionECG technology for sale. Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or
5/26/15 - Lumicell Reports FDA Approval to Launch Feasibility Study [Health & Beauty Close - Up]
Lumicell recently received Investigational Device Exemption approval from the U.S. Food and Drug Administration to launch a feasibility study for intraoperative imaging of breast cancer during surgery. The study will be conducted at Massachusetts General Hospital. Barbara Smith, Director, Breast Cancer Program and Co-Director, Gillette Center for..
5/26/15 - Nitiloop Reports FDA 510(k) Clearance for Its NovaCross Microcatheter [Professional Services Close - Up]
Nitiloop recently reported that it has received FDA clearance for its first product, NovaCross, which is intended to be used in conjunction with a guidewire to access discrete regions of the coronary or peripheral vasculature. According to a release, in addition to the recent granting of FDA clearance, the company reported successful results from a

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement